Non–Vitamin K Antagonist Oral Anticoagulants and Factors Influencing the Ischemic and Bleeding Risk in Elderly Patients With Atrial Fibrillation: A Review of Current Evidence

Non–vitamin K antagonist oral anticoagulants (NOACs) are a widely prescribed treatment to prevent stroke in patients with nonvalvular atrial fibrillation, and a therapy and preventative measure to prevent recurrences following venous thromboembolism. Optimal use of NOACs requires a thorough knowledg...

Descripción completa

Detalles Bibliográficos
Autores principales: Patti, Giuseppe, Haas, Sylvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Cardiovascular Pharmacology 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774815/
https://www.ncbi.nlm.nih.gov/pubmed/33060545
http://dx.doi.org/10.1097/FJC.0000000000000927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774815/
https://www.ncbi.nlm.nih.gov/pubmed/33060545
http://dx.doi.org/10.1097/FJC.0000000000000927

Ejemplares similares